Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
96.4M
-
Shares change
-
+92.1M
-
Total reported value, excl. options
-
$776M
-
Value change
-
+$741M
-
Number of buys
-
84
-
Price
-
$8.05
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2015
85 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2015.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.4M shares
of 363M outstanding shares and own 26.55% of the company stock.
Largest 10 shareholders include Artal Group S.A. (57.5M shares), FMR LLC (14.9M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (6.47M shares), Ulys, L.L.C. (4.32M shares), VANGUARD GROUP INC (2.86M shares), BlackRock Fund Advisors (2.29M shares), BlackRock Institutional Trust Company, N.A. (1.19M shares), MASTERS CAPITAL MANAGEMENT LLC (1.13M shares), TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY (738K shares), and STATE STREET CORP (559K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.